An analysis and structural modeling of the SARS-CoV-2 spike protein, the area of the virus that facilitates entry into a cell, reveals a unique feature...
A team of researchers from Utrecht University, the Erasmus Medical Center and Harbour BioMed has identified a human monoclonal antibody that neutralizes...
In a paper published in the journal Frontiers in Microbiology, a team of researchers at the University of North Carolina at Chapel Hill review possible...
An orally bioavailable prodrug called EIDD-2801 (β-D-N4-hydroxycytidine-5’-isopropyl ester) has broad spectrum antiviral activity against SARS-CoV-2,...
Two new papers published in the journal Antimicrobial Agents and Chemotherapy provide a summary of therapeutic compounds that showed potential in fighting...
An analysis of the genomes of SARS-CoV-2, a novel coronavirus which causes COVID-19 disease, and related coronaviruses found no evidence that the virus...
A novel human coronavirus that is now named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged in Wuhan, China, in 2019 and is now causing...
